Cazanat 40mg Tablet

Product Description

Cazanat 40mg Tablet contains Cabozantinib as its active ingredient. By blocking many receptor tyrosine kinases (RTKs) involved in tumor growth, metastasis, and angiogenesis, the tyrosine kinase inhibitor (TKI) cabotinib is used to treat a variety of cancer types.

Brand Name: Cazanat

Composition: Cabozantinib

Mechanism of Action:

Multiple tyrosine kinases, such as MET, VEGFR, and RET, which are implicated in several pathways essential for tumor cell development and angiogenesis (blood vessel creation), are inhibited by cabotinib. Cabozantinib can decrease the blood supply to tumors and impede the growth and spread of cancer cells by blocking these kinases.

Uses:

• Liver Cancer
• Kidney Cancer
• Medullary thyroid Cancer

Dosage and Administration:

Depending on the type of cancer being treated and patient characteristics like liver or renal function, the usual dosage for Cazanat is 60 mg once daily. It must be taken at least two hours before or after a meal, on an empty stomach.

Side Effects:

• Diarrhea
• Fatigue
• Nausea
• Vomiting
• Anemia
• Decreased appetite
• Weight loss
• Elevated liver enzymes
• Hypertension (high blood pressure)
• Palmar-plantar erythrodysesthesia (hand-foot syndrome)